Scientific Opinion on the substantiation of health claims related to alpha lipoic acid and protection of body lipids from oxidative damage (ID 1434, 3134), maintenance of normal blood cholesterol concentrations (ID 3134), increased beta-oxidation of fatty acids (ID 3134), maintenance of normal blood glucose concentrations (ID 1435, 3162), and "regeneration of genes, regeneration of gene transcription and the influence to activity NF kappa B" (ID 3133) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Tabs

Article
Alpha-lipoic acid, oxidative damage, cholesterol, beta-oxidation, fatty acids, blood glucose, regeneration of genes, regeneration of gene transcription, NF-kappa B activity, health claims
First published in the EFSA Journal
25 February 2010
Adopted
21 December 2009
Type
Opinion of the Scientific Committee/Scientific Panel
Abstract

No abstract available

Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren, and Hans Verhagen.
Panel on Dietetic Products, Nutrition and Allergies
Contact
doi
10.2903/j.efsa.2010.1474
EFSA Journal 2010; 8(2):1474 [18 pp.].
On request from
European Commission
Print on demand
Number of Pages
18